AMR Clinical, a US-based, multi-site research company, said on Monday it has acquired ClinOhio Research Services (ClinOhio), a multi-therapeutic research site founded in 2017 and based in Columbus, Ohio.
AMR says that the acquisition expands its geographic presence and strengthens capabilities in Dermatology, Women's Health, and Gastroenterology.
ClinOhio is involved in clinical research across several therapeutic areas. Its investigators bring experience in Dermatology, Women's Health, and Gastroenterology and are foundationally positioned to expand into additional specialties. This addition is expected to enhance AMR's capabilities and provide sponsors with improved access to patient populations in the Columbus market.
Integration with AMR is intended to leverage the company's established operational infrastructure, centralised support functions, sponsor relationships, and data capabilities to drive continued growth at the site, expand trial complexity, and enhance execution consistency across programs.
Evommune reports Phase 2b trial miss for EVO756 in chronic spontaneous urticaria
AbbVie receives positive CHMP opinion for upadacitinib in non‑segmental vitiligo
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Racura Oncology doses first patient in Phase 1 lung cancer trial
NeuroSense reports Phase 2 proof-of-concept study results for PrimeC in Alzheimer's Disease
Servier enrols first US patient in Phase Ib/II paediatric epilepsy study
Dicot Pharma receives FDA clearance to start Phase 2b study of LIB-01 in US
CeleCor Therapeutics submits final section of zalunfiban (Disaggpro) New Drug Application to US FDA
Vascarta announces VAS-101 Phase I results in sickle cell disease patients